Related Experiment Video

Updated: May 12, 2025

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

378

Therapeutic mRNA vaccine applications in oncology

Leighton Elliott1, Timothy Foster2, Paul Castillo3

  • 1Department of Medicine, Division of Hematology & Oncology, University of Florida, Gainesville, FL 32608, USA; Department of Pediatrics, Division of Pediatric Hematology-Oncology, University of Florida, Gainesville, FL 32610, USA.

Molecular Therapy : the Journal of the American Society of Gene Therapy
|May 8, 2025
PubMed

Insights

Messenger RNA (mRNA) vaccines, initially for infectious diseases, show promise for cancer treatment. Lipid nanoparticles enhance delivery, paving the way for personalized cancer vaccines.

Area of Science:

  • Biotechnology
  • Vaccinology
  • Oncology

Background:

  • Messenger RNA (mRNA) vaccines have revolutionized infectious disease prevention.
  • Lipid nanoparticles (LNPs) are crucial for protecting mRNA and facilitating in vivo delivery.
  • The potential of mRNA technology extends beyond infectious diseases to other therapeutic areas, notably cancer.

Purpose of the Study:

  • To review the mechanisms and enhancement potential of mRNA vaccines.
  • To summarize the clinical progress of mRNA cancer vaccines.
  • To discuss the implications of mRNA localization and response correlates in cancer therapy.

Main Methods:

  • Literature review of mRNA vaccine technology.
  • Analysis of clinical trial data for mRNA cancer vaccines.
  • Examination of biological response markers and mRNA localization studies.

Main Results:

  • mRNA vaccines demonstrate significant potential for cancer treatment applications.
  • Clinical development of mRNA cancer vaccines is advancing rapidly.
  • Understanding mRNA localization and biologic responses is key to optimizing efficacy.

Conclusions:

  • mRNA technology is a promising platform for developing personalized cancer vaccines.
  • Advances in LNP delivery systems enhance the therapeutic capacity of mRNA.
  • Emerging mRNA biotechnologies are well-positioned for success in treating personalized diseases like cancer.
Keywords:
autoimmunitycancerimmunopathologyimmunotherapymRNA vaccinestolerance

More Related Videos

In Vitro Synthesis of Modified mRNA for Induction of Protein Expression in Human Cells10:07

In Vitro Synthesis of Modified mRNA for Induction of Protein Expression in Human Cells

Published on: November 13, 2014

24.9K
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.4K

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
251
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
401
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.4K
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
24.9K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K